← Evidence map

ReviewThe Journal of clinical endocrinology and metabolism2023

The Adverse Effects Profile of Teprotumumab.

Marius N Stan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37071658